AlphAIAlphAI — Financial news for AI agents
quiverquant.comAUG 201 min read$CXT

Fund Update: New $93.1M $CXT stock position opened by DEPRINCE RACE & ZOLLO INC

DEPRINCE RACE & ZOLLO INC opened a $93.1M position in CXT, according to a recent SEC 13F filing. 179 institutional investors increased their CXT holdings, while 201 decreased theirs in Q2 2026. Notable moves include additions by BLACKROCK and INVESCO, and removals by WELLINGTON MANAGEMENT and CAPITAL INTERNATIONAL.

Original reporting
quiverquant.com
Published Aug 20, 2026, 3:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 10:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Fund Update: New $93.1M $CXT stock position opened by DEPRINCE RACE & ZOLLO INC — source image
Source · quiverquant.com
Decision brief

The 30-second read

$CXTBullishMed
01

Why it matters

The disclosed stake may attract other investors and increase liquidity for CXT.

02

Market read

Fresh 13F data provides actionable insight into institutional sentiment toward CXT.

03

What to watch

Potential upcoming clinical data or regulatory events for CXT not disclosed.

Relevance 8/10Novelty 7/10Timing: post‑filing Aug 20 2026

Background

13F filings reveal institutional holdings; new large positions can influence market perception.

Company-level read

Ticker impact

$CXTBullishMedium confidence
Context

DEPRINCE RACE & ZOLLO INC disclosed a new $93.1M long position in CXT via its Q2 2026 13F filing.

Expected impact

Potential modest upside as the market absorbs the new demand.

Evidence & confidence

The filing is the first public disclosure of a sizable $93M stake, indicating fresh interest from a hedge fund.

Market effects

Sector

May highlight growing interest in the biotech/health‑care sector.

Regional

Limited to US equity markets where CXT trades.

Global

Low; primarily affects investors tracking CXT.

Counterpoint

What could challenge this read

The stake could be a short‑term tactical move; price may not sustain.

Key entities

  • Hedge Fund
    DEPRINCE RACE & ZOLLO INC

    Institutional investor filing a 13F.

  • Company
    CXT

    Publicly traded company receiving a $93M stake.

Read at source← All news

Related articles

SEP 22
$CXTHigh

Crane NXT (CXT) Stock Trades Up, Here Is Why

Crane NXT (CXT) shares rose 6.4% after Jefferies analyst Stephen Volkmann initiated coverage with a Buy rating and $60.00 price target, implying 31% upside. Volkmann cited underappreciated security-technology advantages. The stock has seen volatility, with a 13.5% gain last year on U.S. Currency business growth expectations. CXT is up 1.9% YTD but 29.4% below its 52-week high.

financialcontent.com2 min
SEP 22
$CXTMed

Why is Crane NXT stock climbing today?

Crane NXT (CXT) stock rose 2.7% in pre-market trading after Jefferies initiated coverage with a Buy rating and $60 price target. The firm cited strong Q2 2026 results, including 22% revenue growth and raised earnings guidance. The company's backlog reached $755.5 million, reflecting 17% average year-over-year growth over two years.

investing.com2 min
AUG 24
$CXTMedAI 8/10

Moody’s downgrades Crane NXT senior secured debt on recovery value

Moody's downgraded Crane NXT's senior secured debt to Ba1 from Baa3 due to lower recovery value expectations. The company's corporate family rating was affirmed at Ba1, with a stable outlook. Moody's cited Crane NXT's robust performance and low leverage but noted risks from its small scale and potential debt-financed acquisitions. The company is expected to maintain good liquidity and generate around $200 million in free cash flow in 2026 and 2027.

investing.com2 min
AUG 24
$CXTLow

Crane NXT (CXT) Could Be 25% Below Fair Value As New President Takes Key Role

Crane NXT (CXT) appointed Jason Lund as President of Crane Payment Innovations and Group President of its Detection and Traceability Technologies segment. The stock trades at $50.20, with a 90-day return of 23.07% but a 1-year return of -18.55%. Analysts suggest it may be 25% undervalued at $66.83, citing growth potential in authentication and cybersecurity, though digital payment shifts and acquisition risks remain.

simplywall.st2 min